Global Healthcare ETF - Currency Hedged | BetaShares
  • Request info pack
  • Download factsheet
  • Request a call
  • Request Lonsec research

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

About

Provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector

  • Tactical exposure to the global healthcare sector
  • A core component of a global equities allocation providing transparency and diversification benefits

Advantages

  • Access – simple way to access a diversified portfolio of the world’s largest healthcare companies
  • Reduced currency risk – foreign currency exposure hedged to the Australian dollar
  • Diversification – with a single trade, investors can get exposure to a diversified portfolio of healthcare companies from a broad range of global locations
  • Cost effective – Fund aims to track the performance of an index (no ‘active manager’ fees)
  • Large company exposure – strategy invests only in the most significant healthcare companies globally
  • No W-8 BEN forms and no US estate tax implications for investors – simplified tax administration, unlike cross-listed alternatives
  • Liquidity – available to trade on ASX like any share

How to Invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX
  • Fund requires no minimum investment

KEY FACTS

Pricing Information 10 December 2019

Current Price
Last Trade* $6.46
% Change (prev day) 0%
Bid (delayed) $6.40
Offer (delayed) $6.46
*Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit * $6.47
* As at 6 December 2019

Profile

Net Assets* ($A) $32,423,520
Units Outstanding* (#) 5,010,204
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 6 December 2019
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN INDEX
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 8.0
UNITEDHEALTH GROUP INC 5.8
NOVARTIS AG-REG 5.4
MERCK & CO. INC. 5.0
ROCHE HOLDING AG-GENUSSCHEIN 5.0
PFIZER INC 3.9
MEDTRONIC PLC 3.3
ABBOTT LABORATORIES 3.3
AMGEN INC 3.1
THERMO FISHER SCIENTIFIC INC 3.0
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 8.0 Equities Healthcare United States USD 12,453 $2,561,708 $2,561,708
UNH UN UNITEDHEALTH GROUP INC 5.8 Equities Healthcare United States USD 4,535 $1,842,817 $1,842,817
NOVN SW NOVARTIS AG-REG 5.4 Equities Healthcare Switzerland CHF 12,864 $1,738,203 $1,738,203
MRK UN MERCK & CO. INC. 5.0 Equities Healthcare United States USD 12,380 $1,608,131 $1,608,131
ROG SW ROCHE HOLDING AG-GENUSSCHEIN 5.0 Equities Healthcare Switzerland CHF 3,576 $1,607,822 $1,607,822
PFE UN PFIZER INC 3.9 Equities Healthcare United States USD 22,483 $1,261,418 $1,261,418
MDT UN MEDTRONIC PLC 3.3 Equities Healthcare United States USD 6,563 $1,067,857 $1,067,857
ABT UN ABBOTT LABORATORIES 3.3 Equities Healthcare United States USD 8,462 $1,039,104 $1,039,104
AMGN UW AMGEN INC 3.1 Equities Healthcare United States USD 2,933 $999,797 $999,797
TMO UN THERMO FISHER SCIENTIFIC INC 3.0 Equities Healthcare United States USD 2,062 $955,313 $955,313
ABBV UN ABBVIE INC 2.8 Equities Healthcare United States USD 7,079 $895,913 $895,913
AZN LN ASTRAZENECA PLC 2.7 Equities Healthcare Britain GBP 6,214 $863,926 $863,926
GSK LN GLAXOSMITHKLINE PLC 2.5 Equities Healthcare Britain GBP 23,886 $794,759 $794,759
LLY UN ELI LILLY & CO 2.4 Equities Healthcare United States USD 4,374 $770,029 $770,029
BMY UN BRISTOL-MYERS SQUIBB CO 2.4 Equities Healthcare United States USD 8,422 $755,637 $755,637
NOVOB DC NOVO NORDISK A/S-B 2.3 Equities Healthcare Denmark DKK 8,822 $735,581 $735,581
SAN FP SANOFI 2.3 Equities Healthcare France EUR 5,479 $726,451 $726,451
GILD UW GILEAD SCIENCES INC 1.8 Equities Healthcare United States USD 5,738 $562,290 $562,290
ANTM UN ANTHEM INC 1.6 Equities Healthcare United States USD 1,225 $506,375 $506,375
BAYN GY BAYER AG-REG 1.6 Equities Healthcare Germany EUR 4,513 $501,079 $501,079
SYK UN STRYKER CORP 1.5 Equities Healthcare United States USD 1,657 $486,183 $486,183
CI UN CIGNA CORP 1.5 Equities Healthcare United States USD 1,691 $485,141 $485,141
BDX UN BECTON DICKINSON AND CO 1.4 Equities Healthcare United States USD 1,209 $456,517 $456,517
4502 JT TAKEDA PHARMACEUTICAL CO LTD 1.4 Equities Healthcare Japan JPY 7,600 $447,770 $447,770
ZTS UN ZOETIS INC 1.4 Equities Healthcare United States USD 2,459 $436,463 $436,463
ISRG UW INTUITIVE SURGICAL INC 1.3 Equities Healthcare United States USD 504 $422,954 $422,954
BSX UN BOSTON SCIENTIFIC CORP 1.2 Equities Healthcare United States USD 6,062 $387,950 $387,950
BIIB UW BIOGEN INC 1.1 Equities Healthcare United States USD 842 $364,353 $364,353
EW UN EDWARDS LIFESCIENCES CORP 1.1 Equities Healthcare United States USD 1,036 $355,380 $355,380
EL FP ESSILOR INTERNATIONAL 1.1 Equities Consumer Discretionary France EUR 1,555 $345,807 $345,807
VRTX UW VERTEX PHARMACEUTICALS INC 1.0 Equities Healthcare United States USD 1,024 $328,894 $328,894
PHIA NA KONINKLIJKE PHILIPS NV 1.0 Equities Healthcare Netherlands EUR 4,462 $308,958 $308,958
ILMN UW ILLUMINA INC 1.0 Equities Healthcare United States USD 639 $305,551 $305,551
BAX UN BAXTER INTERNATIONAL INC 1.0 Equities Healthcare United States USD 2,543 $303,633 $303,633
HCA UN HCA HOLDINGS INC 0.9 Equities Healthcare United States USD 1,430 $299,065 $299,065
HUM UN HUMANA INC 0.9 Equities Healthcare United States USD 581 $291,164 $291,164
4568 JT DAIICHI SANKYO CO LTD 0.9 Equities Healthcare Japan JPY 3,100 $289,279 $289,279
7741 JP HOYA CORP 0.8 Equities Healthcare Japan JPY 1,900 $254,617 $254,617
4503 JT ASTELLAS PHARMA INC 0.7 Equities Healthcare Japan JPY 9,400 $237,696 $237,696
ZBH UN ZIMMER BIOMET HLDGS 0.7 Equities Healthcare United States USD 1,023 $219,758 $219,758
REGN UW REGENERON PHARMACEUTICALS 0.7 Equities Healthcare United States USD 402 $215,202 $215,202
IQV UN IQVIA HOLDINGS INC 0.6 Equities Healthcare United States USD 965 $206,846 $206,846
LONN SW LONZA GROUP AG-REG 0.6 Equities Healthcare Switzerland CHF 390 $194,769 $194,769
ALC SW ALCON INC 0.6 Equities Healthcare Switzerland CHF 2,353 $191,190 $191,190
4543 JT TERUMO CORP 0.6 Equities Healthcare Japan JPY 3,500 $178,659 $178,659
4578 JT OTSUKA HOLDINGS CO LTD 0.5 Equities Healthcare Japan JPY 2,600 $170,707 $170,707
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.5 Equities Healthcare Japan JPY 1,200 $158,352 $158,352
COLOB DC COLOPLAST-B 0.5 Equities Healthcare Denmark DKK 924 $157,632 $157,632
ALGN UW ALIGN TECHNOLOGY INC 0.5 Equities Healthcare United States USD 389 $155,748 $155,748
FRE GY FRESENIUS SE & CO KGAA 0.5 Equities Healthcare Germany EUR 1,898 $152,095 $152,095
ALXN UW ALEXION PHARMACEUTICALS INC 0.5 Equities Healthcare United States USD 917 $151,016 $151,016
CNC UN CENTENE CORP 0.5 Equities Healthcare United States USD 1,735 $150,307 $150,307
INCY UW INCYTE CORP 0.5 Equities Healthcare United States USD 1,072 $148,777 $148,777
RMD US RESMED INC 0.5 Equities Healthcare United States USD 670 $146,478 $146,478
IDXX UW IDEXX LABORATORIES INC 0.5 Equities Healthcare United States USD 401 $146,204 $146,204
SN/ LN SMITH & NEPHEW PLC 0.4 Equities Healthcare Britain GBP 4,356 $140,501 $140,501
4507 JT SHIONOGI & CO LTD 0.4 Equities Healthcare Japan JPY 1,600 $138,112 $138,112
FME GY FRESENIUS MEDICAL CARE AG & 0.4 Equities Healthcare Germany EUR 1,101 $115,628 $115,628
COO US COOPER COS INC/THE 0.3 Equities Healthcare United States USD 218 $96,475 $96,475
068270 KS CELLTRION INC 0.3 Equities Healthcare South Korea KRW 417 $86,154 $86,154
JPY JPY - Japanese Yen 0.0 Cash JPY 1,111,339 $14,980 $14,980
GBP GBP - British Pound 0.0 Cash GBP 4,956 $9,540 $9,540
AUD AUD - Australia Dollar 0.0 Cash AUD 4,588 $4,588 $4,588
DKK DKK - Danish Krone 0.0 Cash DKK 10,582 $2,294 $2,294
USD USD - United States Dollar 0.0 Cash USD 1,198 $1,754 $1,754
CHF CHF - Swiss Franc 0.0 Cash CHF 930 $1,379 $1,379
EUR EUR - Euro 0.0 Cash EUR 434 $702 $702
CAD CAD - Canada Dollar 0.0 Cash CAD 133 $147 $147
KRW KRW - Korean Won Cash KRW 1 $0 $0
AUD AUD - Australia Dollar FX Forwards AUD 32,202,642 $32,202,642
CHF CHF - Swiss Franc FX Forwards CHF -2,550,586 -$3,779,766
DKK DKK - Danish Krone FX Forwards DKK -4,123,685 -$893,888
EUR EUR - Euro FX Forwards EUR -1,345,441 -$2,179,205
GBP GBP - British Pound FX Forwards GBP -962,540 -$1,852,963
JPY JPY - Japanese Yen FX Forwards JPY -140,459,634 -$1,893,268
USD USD - United States Dollar FX Forwards USD -14,612,838 -$21,395,078
Download CSV
* As at 9 December 2019

Sector Allocation

Healthcare
100.0%
* As of 31 October 2019

Country Allocation

United States
66.4%
Switzerland
11.8%
Britain
5.9%
Japan
5.8%
France
3.5%
Denmark
2.8%
Germany
2.5%
Netherlands
0.9%
South Korea
0.3%
* As of 31 October 2019

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month 4.10% 4.14%
3 months 8.70% 8.84%
6 months 14.68% 15.01%
1 year 7.06% 6.77%
3 year p.a 13.44% 13.67%
5 year p.a - 8.17%
Since inception (p.a) 9.21% 9.43%
Inception date 4-Aug-16 -
* As at 29 November 2019

Chart

Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 0.3%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 31 October 2019. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.71%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
The Investment Case for DRUG
Download
Product Disclosure Statement - Global Sector Series
Download
Annual Report - June 2019
Download
NRWT and Fund Payment Notice information – December 2018 distributions
Download
Notice of Modifications to Fund Constitution – AMIT Tax Regime
Download
Index Methodology
Download
2018 Distribution Calendar
Download
Interim Financial Report 2018
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack